Sandip Kapadia - 30 Sep 2025 Form 4 Insider Report for Harmony Biosciences Holdings, Inc. (HRMY)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Christian Ulrich, Attorney-in-Fact
Issuer symbol
HRMY
Transactions as of
30 Sep 2025
Net transactions value
-$662,515
Form type
4
Filing time
02 Oct 2025, 16:05:07 UTC
Previous filing
19 Aug 2025
Next filing
25 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kapadia Sandip CHIEF FINANCIAL OFFICER C/O HARMONY BIOSCIENCES HOLDINGS, INC., 630 W GERMANTOWN PIKE, SUITE 215, PLYMOUTH MEETING /s/ Christian Ulrich, Attorney-in-Fact 02 Oct 2025 0001677141

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HRMY Common Stock Options Exercise $0 +45,000 $0.000000 45,000 30 Sep 2025 Direct
transaction HRMY Common Stock Tax liability $662,515 -24,039 -53% $27.56 20,961 30 Sep 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HRMY Restricted Stock Units Options Exercise $0 -45,000 -50% $0.000000 45,000 30 Sep 2025 Common Stock 45,000 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date.
F2 The restricted stock units were granted on October 4, 2023. 40% of the restricted stock units shall vest on September 30, 2024 and 30% shall vest on each of September 30, 2025 and September 30, 2026. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.